High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic LeukemiaStephan Müller, Evelyn Ullrich, Franziska Kalensee et al.|Frontiers in Immunology|2020Cited by 111
Immunotherapy with NK cells: recent developments in gene modification open up new avenuesLisa Marie Reindl, Evelyn Ullrich, Nawid Albinger et al.|OncoImmunology|2020Cited by 41
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytesLaura Kapitza, Jessica Hartmann|Frontiers in Immunology|2023Cited by 10